Stem Cell Research (Jul 2022)

Generation of an induced pluripotent stem cell line (UCSCi002-A) from a patient with a variant in TARDBP gene associated with familial amyotrophic lateral sclerosis and frontotemporal dementia

  • Francesco Martello,
  • Serena Lattante,
  • Paolo Niccolò Doronzio,
  • Amelia Conte,
  • Giulia Bisogni,
  • Daniela Orteschi,
  • Marco Luigetti,
  • Maria Alessandra Marrucci,
  • Marcella Zollino,
  • Mario Sabatelli,
  • Giuseppe Marangi

Journal volume & issue
Vol. 62
p. 102825

Abstract

Read online

Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease that selectively affects motor neurons. In 20% of cases, ALS appears in comorbidity with frontotemporal dementia (FTD). We generated patient-derived-induced Pluripotent Stem Cells (iPSCs), from an ALS/FTD patient. The patient had a familial form of the disease and a missense variant in TARDBP gene. We used an established protocol based on Sendai virus to reprogram fibroblasts. We confirmed the stemness and the pluripotency of the iPSC clones, thus generating embryoid bodies. We believe that the iPSC line carrying a TARDBP mutation could be a valuable tool to investigate TDP-43 proteinopathy linked to ALS.